% Expired Patents = 100.0

Forward Citations = 0

Loading Chart...

2 inventors (with patents filed for the assignee):

Lasse Leino (4 out of 7 patents)

Jarmo Laihia (4 out of 4 patents)

4 patents: Sort by Forward Citations

1. 8673281 - Pharmaceutical composition for intracellular acidification with cis-urocanic acid (2014-03-18),

2. 8673280 - Pharmaceutical composition for intracellar acidification with cis-urocanic acid (2014-03-18),

3. 8338475 - Anti-proliferative pharmaceutical composition (2012-12-25),

4. 8313738 - Pharmaceutical composition for intracellular acidification with cis-urocanic acid (2012-11-20),

Company Overview

Biocis Pharma Oy is a Finnish biotechnology company focusing on the discovery and development of new innovative treatments for autoimmune diseases and cancer. The company utilizes its proprietary technology platform to identify novel drug candidates and advance them through preclinical and clinical development. Biocis Pharma is committed to improving patient outcomes and addressing unmet medical needs through its cutting-edge research and development efforts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#30 in Turku

#642 in Finland

Turku, Finland

Biocis Pharma Oy

Forward Citations = 0

2 inventors:

Lasse Leino (4 out of 7 patents)

Jarmo Laihia (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biocis Pharma Oy. Retrieved from https://idiyas.com/company/biocis-pharma-oy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]